Search research articles
Contact Us
Filters
Showing results (41-50 of 47) with videos related to
Page
of 5
Sort By:
You have reached the last page of results.
This site can display upto 47 results.
Diabetes Research and Clinical Practice
|
May 26, 2020
Prevalence of microvascular and macrovascular disease in the Glycemia Reduction Approaches in Diabetes - A Comparative Effectiveness (GRADE) Study cohort
Kieren J Mather, Ionut Bebu, Chelsea Baker, et al.
Diabetes Care
|
June 21, 2014
Basal insulin peglispro demonstrates preferential hepatic versus peripheral action relative to insulin glargine in healthy subjects
Robert R Henry, Sunder Mudaliar, Theodore P Ciaraldi, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
March 1, 2024
Repositioning the Early Pathology of Type 1 Diabetes to the Extraislet Vasculature
Anne Costanzo, Don Clarke, Marie Holt, et al.
Nature Medicine
|
October 3, 2022
Glucagon receptor antagonist volagidemab in type 1 diabetes: a 12-week, randomized, double-blind, phase 2 trial
Jeremy Pettus, Schafer C Boeder, Mark P Christiansen, et al.
Frontiers in Immunology
|
October 16, 2024
TNF-α inhibitors for type 1 diabetes: exploring the path to a pivotal clinical trial
Cassandra Bazile, Magdy M Abdel Malik, Courtney Ackeifi, et al.
Cardiovascular Diabetology
|
March 17, 2023
CVOT Summit 2022 Report: new cardiovascular, kidney, and glycemic outcomes
Oliver Schnell, Tadej Battelino, Richard Bergenstal, et al.
The New England Journal of Medicine
|
September 28, 2022
Multicenter, Randomized Trial of a Bionic Pancreas in Type 1 Diabetes
, Steven J Russell, Roy W Beck, et al.
Page
of 5
Search research articles
Search
Showing results (41-50 of 47) with videos related to
Sort By:
Page
of 5
You have reached the last page of results.
This site can display upto 47 results.
Diabetes Research and Clinical Practice
|
May 26, 2020
Prevalence of microvascular and macrovascular disease in the Glycemia Reduction Approaches in Diabetes - A Comparative Effectiveness (GRADE) Study cohort
Kieren J Mather, Ionut Bebu, Chelsea Baker, et al.
Diabetes Care
|
June 21, 2014
Basal insulin peglispro demonstrates preferential hepatic versus peripheral action relative to insulin glargine in healthy subjects
Robert R Henry, Sunder Mudaliar, Theodore P Ciaraldi, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
March 1, 2024
Repositioning the Early Pathology of Type 1 Diabetes to the Extraislet Vasculature
Anne Costanzo, Don Clarke, Marie Holt, et al.
Nature Medicine
|
October 3, 2022
Glucagon receptor antagonist volagidemab in type 1 diabetes: a 12-week, randomized, double-blind, phase 2 trial
Jeremy Pettus, Schafer C Boeder, Mark P Christiansen, et al.
Frontiers in Immunology
|
October 16, 2024
TNF-α inhibitors for type 1 diabetes: exploring the path to a pivotal clinical trial
Cassandra Bazile, Magdy M Abdel Malik, Courtney Ackeifi, et al.
Cardiovascular Diabetology
|
March 17, 2023
CVOT Summit 2022 Report: new cardiovascular, kidney, and glycemic outcomes
Oliver Schnell, Tadej Battelino, Richard Bergenstal, et al.
The New England Journal of Medicine
|
September 28, 2022
Multicenter, Randomized Trial of a Bionic Pancreas in Type 1 Diabetes
, Steven J Russell, Roy W Beck, et al.
Page
of 5